How the stock could nearly double by the end of 2029.
Contrary to a common assumption, not every car company overcommitted to an unexpectedly tepid EV market.
Jacobs Solutions stands to be a beneficiary of the red-hot weight loss movement fueling the pharmaceutical market.
The energy giant has a high yield, a strong business, and it's shifting along with the world around it.
This REIT is down materially from its 2022 highs, but it continues to operate at a high level as it benefits from a unique regional focus.
Berkshire Hathaway can't stop buying shares of this insurance titan.
While he has more than two dozen stocks in his portfolio, four make up the vast majority of his holdings.
These alternatives to Apple all have excellent stock return prospects.
The president's impact on the economy is generally exaggerated.
